136 related articles for article (PubMed ID: 16434604)
1. Combined effects of the p53 and p73 polymorphisms on lung cancer risk.
Schabath MB; Wu X; Wei Q; Li G; Gu J; Spitz MR
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):158-61. PubMed ID: 16434604
[TBL] [Abstract][Full Text] [Related]
2. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer.
Li G; Wang LE; Chamberlain RM; Amos CI; Spitz MR; Wei Q
Cancer Res; 2004 Oct; 64(19):6863-6. PubMed ID: 15466174
[TBL] [Abstract][Full Text] [Related]
3. A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population.
Gallì P; Cadoni G; Volante M; De Feo E; Amore R; Giorgio A; Arzani D; Paludetti G; Ricciardi G; Boccia S
BMC Cancer; 2009 May; 9():137. PubMed ID: 19426493
[TBL] [Abstract][Full Text] [Related]
4. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Amos CI; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Carcinogenesis; 2004 Oct; 25(10):1911-6. PubMed ID: 15180941
[TBL] [Abstract][Full Text] [Related]
5. [Association of the responsiveness of advanced non-small cell lung cancer to platinum-based chemotherapy with p53 and p73 polymorphisms].
Yuan P; Miao XP; Zhang XM; Wang ZH; Tan W; Zhang XR; Sun Y; Xu BH; Lin DX
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):107-10. PubMed ID: 16750013
[TBL] [Abstract][Full Text] [Related]
6. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
[TBL] [Abstract][Full Text] [Related]
7. p73 G4C14-to-A4T14 gene polymorphism and interaction with p53 exon 4 Arg72Pro on cancer susceptibility: a meta-analysis of the literature.
De Feo E; Simone B; Kamgaing RS; Gallì P; Hamajima N; Hu Z; Li G; Li Y; Matsuo K; Park JY; Roychoudhury S; Spitz MR; Wei Q; Zhang JH; Ricciardi W; Boccia S
Mutagenesis; 2012 May; 27(3):267-73. PubMed ID: 21976716
[TBL] [Abstract][Full Text] [Related]
8. Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population.
Hu Z; Miao X; Ma H; Tan W; Wang X; Lu D; Wei Q; Lin D; Shen H
Int J Cancer; 2005 Apr; 114(3):455-60. PubMed ID: 15578704
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers.
Chen X; Sturgis EM; El-Naggar AK; Wei Q; Li G
Carcinogenesis; 2008 Nov; 29(11):2120-5. PubMed ID: 18701437
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese.
Niwa Y; Hamajima N; Atsuta Y; Yamamoto K; Tamakoshi A; Saito T; Hirose K; Nakanishi T; Nawa A; Kuzuya K; Tajima K
Cancer Lett; 2004 Mar; 205(1):55-60. PubMed ID: 15036661
[TBL] [Abstract][Full Text] [Related]
11. No association between p73 G4C14-to-A4T14 polymorphism and the risk of lung cancer in a Korean population.
Choi JE; Kang HG; Chae MH; Kim EJ; Lee WK; Cha SI; Kim CH; Jung TH; Park JY
Biochem Genet; 2006 Dec; 44(11-12):543-50. PubMed ID: 17136456
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in Japanese.
Hishida A; Matsuo K; Tajima K; Ogura M; Kagami Y; Taji H; Morishima Y; Emi N; Naoe T; Hamajima N
Leuk Lymphoma; 2004 May; 45(5):957-64. PubMed ID: 15291355
[TBL] [Abstract][Full Text] [Related]
13. Role of functional polymorphisms of P53 and P73 genes with the risk of prostate cancer in a case-control study from Northern India.
Mittal RD; George GP; Mishra J; Mittal T; Kapoor R
Arch Med Res; 2011 Feb; 42(2):122-7. PubMed ID: 21565625
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival.
Liu L; Wu C; Wang Y; Zhong R; Duan S; Wei S; Lin S; Zhang X; Tan W; Yu D; Nie S; Miao X; Lin D
J Thorac Oncol; 2011 Nov; 6(11):1793-800. PubMed ID: 21841506
[TBL] [Abstract][Full Text] [Related]
15. Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer.
Jun HJ; Park SH; Lee WK; Choi JE; Jang JS; Kim EJ; Cha SI; Kim DS; Kam S; Kim CH; Kang YM; Jung TH; Park JY
Mol Carcinog; 2007 Feb; 46(2):100-5. PubMed ID: 17013834
[TBL] [Abstract][Full Text] [Related]
16. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.
Huang XE; Hamajima N; Katsuda N; Matsuo K; Hirose K; Mizutani M; Iwata H; Miura S; Xiang J; Tokudome S; Tajima K
Breast Cancer; 2003; 10(4):307-11. PubMed ID: 14634508
[TBL] [Abstract][Full Text] [Related]
17. p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers.
Chen X; Sturgis EM; Etzel CJ; Wei Q; Li G
Cancer; 2008 Dec; 113(12):3307-14. PubMed ID: 18988287
[TBL] [Abstract][Full Text] [Related]
18. Activation of p73 silent allele in lung cancer.
Mai M; Yokomizo A; Qian C; Yang P; Tindall DJ; Smith DI; Liu W
Cancer Res; 1998 Jun; 58(11):2347-9. PubMed ID: 9622072
[TBL] [Abstract][Full Text] [Related]
19. [Association of two genetic polymorphisms in the 5'untranslated region of exon 2 of the p73 gene and risk of lung cancer].
Hu ZB; Miao XP; Ma HX; Tan W; Niu JY; Lin DX; Shen HB
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Feb; 26(2):106-9. PubMed ID: 15921610
[TBL] [Abstract][Full Text] [Related]
20. Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population.
Umar M; Upadhyay R; Khurana R; Kumar S; Ghoshal UC; Mittal B
Mol Biol Rep; 2012 Feb; 39(2):1153-62. PubMed ID: 21573788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
